SEC Filings | Landos Biopharma

Filing date	Form	Description	View
03/10/22	8-K	Report of unscheduled material events or corporate event	0001193125-22-071348.pdf 0001193125-22-071348.rtf 0001193125-22-071348.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
03/10/22	3	Initial filing by director officer or owner of more than ten percent.	0001209191-22-017863.pdf 0001209191-22-017863.rtf 0001209191-22-017863.xls View HTML
03/10/22	4	Statement of changes in beneficial ownership of securities	0001209191-22-017865.pdf 0001209191-22-017865.rtf 0001209191-22-017865.xls View HTML
02/14/22	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001493152-22-004514.pdf 0001493152-22-004514.rtf 0001493152-22-004514.xls View HTML
02/14/22	5	Annual filing director officer or owner of more than ten percent.	0001843575-22-000001.pdf 0001843575-22-000001.rtf 0001843575-22-000001.xls View HTML
02/03/22	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001193125-22-027077.pdf 0001193125-22-027077.rtf 0001193125-22-027077.xls View HTML
01/13/22	8-K	Report of unscheduled material events or corporate event	0001193125-22-008251.pdf 0001193125-22-008251.rtf 0001193125-22-008251.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
12/21/21	8-K	Report of unscheduled material events or corporate event	0001193125-21-363593.pdf 0001193125-21-363593.rtf 0001193125-21-363593.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
12/21/21	4	Statement of changes in beneficial ownership of securities	0001209191-21-070774.pdf 0001209191-21-070774.rtf 0001209191-21-070774.xls View HTML
12/21/21	4	Statement of changes in beneficial ownership of securities	0001209191-21-070776.pdf 0001209191-21-070776.rtf 0001209191-21-070776.xls View HTML

Data provided by Kaleidoscope.